PCNA analysis and quantification showed a downward trend in TKI‐treated control‐ETV1 or ‐ERG mice, which is consistent with a potential reduction in proliferation in the treated tumour and therefore with a reduction in tumour volume (Fig. S9). The gene discussed is PCNA; the disease is neoplasm.